Akeso, Inc. (HKG:9926)
Hong Kong
· Delayed Price · Currency is HKD 82.95
-0.75 (-0.90%)
Apr 17, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 75.13 billion as of April 16, 2025. Its market cap has increased by 87.65% in one year.
Market Cap
75.13B
Enterprise Value
71.45B
Revenue
2.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
82.95
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 75.13B, an increase of 305.12%. That is a compound annual growth rate of 32.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2025 | 75.13B | 37.89% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 199.57B |
| Hansoh Pharmaceutical Group Company | 131.45B |
| JD Health International | 111.35B |
| WuXi Biologics | 81.77B |
| Innovent Biologics | 79.21B |
| Alibaba Health Information Technology | 73.82B |
| Sino Biopharmaceutical | 66.56B |
| Sichuan Kelun-Biotech Biopharmaceutical | 65.68B |